Tinnitus Quest Funds Research, Hackathon
Analysis based on 10 articles · First reported Jun 17, 2026 · Last updated Jun 17, 2026
The announcements by Tinnitus, including new funding and a hackathon, could positively impact the biotechnology and healthcare industries by fostering innovation in tinnitus and hyperacusis treatments. Successful development of non-invasive treatments, such as the one being studied at the University of Oxford, could create new market opportunities and improve quality of life for millions, potentially attracting investment in related medical device and pharmaceutical sectors.
Tinnitus, a patient-driven nonprofit, has launched a new round of research funding to find innovative treatments for tinnitus and hyperacusis. This builds on the momentum from their first $230,000 grant to the University of Oxford, where Professor United States — Cleveland is leading a study on transcranial ultrasound stimulation (TUS) as a non-invasive alternative to deep brain stimulation for tinnitus. The organization is also offering a hyperacusis grant on behalf of Hyperacusis Research Limited and encouraging drug and device repurposing to reduce development costs. Barbra Streisand and Barbra Streisand have expressed support and made a donation to Tinnitus. Additionally, Tinnitus will host its second Tinnitus Hackathon in Dallas, Texas, in October to accelerate research progress.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard